We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
–
AUM
$735M
AUM Growth
+$57.8M
Cap. Flow
+$11.1M
Cap. Flow %
1.5%
Top 10 Hldgs %
31.1%
Holding
195
New
10
Increased
148
Reduced
29
Closed
4

Top Buys

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$2.33M
2
AAPL icon
Apple
AAPL
+$1.25M
3
BE icon
Bloom Energy
BE
+$903K
4
MLPB icon
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
+$552K
5
CRM icon
Salesforce
CRM
+$365K

Top Sells

Rank Stock Value
1
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$2.15M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$601K
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$576K
4
GLUU
Glu Mobile Inc.
GLUU
+$503K
5
MRNA icon
Moderna
MRNA
+$495K

Sector Composition

Rank Sector Weight
1 Technology 15.29%
2 Healthcare 12.02%
3 Consumer Staples 10.97%
4 Financials 10.35%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VBR icon
26
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$9.3M 1.27%
53,582
+292
+0.5% +$50.6K
BLK icon
27
Blackrock
BLK
$169B
$9.29M 1.26%
10,623
+119
+1% +$101K
MMM icon
28
3M
MMM
$90.9B
$9.15M 1.25%
55,112
+655
+1% +$109K
SWK icon
29
Stanley Black & Decker
SWK
$14.3B
$9.14M 1.24%
44,603
+165
+0.4% +$34.2K
DOV icon
30
Dover
DOV
$27.6B
$9.14M 1.24%
60,701
+440
+0.7% +$64.9K
PG icon
31
Procter & Gamble
PG
$336B
$9.09M 1.24%
67,348
-1,765
-3% -$239K
DOC icon
32
Healthpeak Properties
DOC
$15.1B
$9.02M 1.23%
270,849
+3,450
+1% +$116K
SHW icon
33
Sherwin-Williams
SHW
$82.7B
$9.01M 1.23%
33,062
+188
+0.6% +$51.5K
UNH icon
34
UnitedHealth
UNH
$376B
$8.99M 1.22%
22,446
+278
+1% +$111K
CVX icon
35
Chevron
CVX
$392B
$8.91M 1.21%
85,094
+1,222
+1% +$129K
BA icon
36
Boeing
BA
$171B
$8.91M 1.21%
37,182
-25
-0.1% -$6.04K
JPM icon
37
JPMorgan Chase
JPM
$935B
$8.9M 1.21%
57,201
+457
+0.8% +$71.8K
WMT icon
38
Walmart Inc
WMT
$885B
$8.89M 1.21%
189,072
+1,944
+1% +$90.5K
MCD icon
39
McDonald's
MCD
$192B
$8.8M 1.2%
38,082
-982
-3% -$229K
AMGN icon
40
Amgen
AMGN
$208B
$8.73M 1.19%
35,815
+621
+2% +$153K
PEP icon
41
PepsiCo
PEP
$190B
$8.5M 1.16%
57,379
+579
+1% +$84.4K
MKC icon
42
McCormick & Company Non-Voting
MKC
$13.7B
$8.47M 1.15%
95,963
+1,385
+1% +$124K
MDT icon
43
Medtronic
MDT
$109B
$8.41M 1.14%
67,745
+1,198
+2% +$150K
HRL icon
44
Hormel Foods
HRL
$13.8B
$8.4M 1.14%
175,878
+3,416
+2% +$163K
SBUX icon
45
Starbucks
SBUX
$120B
$8.38M 1.14%
74,980
+876
+1% +$99K
ED icon
46
Consolidated Edison
ED
$40.1B
$8.24M 1.12%
114,908
+1,349
+1% +$104K
JNJ icon
47
Johnson & Johnson
JNJ
$618B
$8.14M 1.11%
49,393
-591
-1% -$97.8K
ABBV icon
48
AbbVie
ABBV
$443B
$8.08M 1.1%
71,752
+1,524
+2% +$172K
ABT icon
49
Abbott
ABT
$183B
$8.07M 1.1%
69,643
+1,562
+2% +$182K
SYY icon
50
Sysco
SYY
$40.8B
$7.94M 1.08%
102,116
+1,026
+1% +$82.9K
1
2
3 4 5

Similar funds

AAM
Artha Asset Management Hoboken, New Jersey $90.3M AUM 27.66% 1-Year Est. Return
AEPBI
AH Equity Partners Bio III Menlo Park, California $95M AUM 50.1% 1-Year Est. Return
MW
Milestone Wealth Buffalo, New York $89.5M AUM 17.2% 1-Year Est. Return
SC
Sarissa Consulting Santa Monica, California $96.9M AUM 29.32% 1-Year Est. Return
NIM
NuWave Investment Management Parsippany, New Jersey $87.2M AUM 38.54% 1-Year Est. Return
WIM
Wilen Investment Management Bonita Springs, Florida $98.1M AUM 2.08% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM
EFEM
Eos Focused Equity Management New York $84.5M AUM 17.48% 1-Year Est. Return

Spearhead Capital Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Spearhead Capital Advisors held 195 positions worth $735M, up 8.5% from $677M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors's Q2 2021 filing shows 10 new, 148 increased, 29 reduced and 4 closed positions. Its largest new stake was Golub Capital BDC: 150,000 shares worth $2.31M. The largest sale was Kiniksa Pharmaceuticals, an estimated $2.15M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Spearhead Capital Advisors's largest Q2 2021 buy was Golub Capital BDC: 150,000 shares worth $2.31M.
  • Spearhead Capital Advisors added most to Apple in Q2 2021, an estimated $1.25M increase.
  • Spearhead Capital Advisors's biggest Q2 2021 reduction was Kiniksa Pharmaceuticals, cutting an estimated $2.15M.
  • Spearhead Capital Advisors fully exited GenMark Diagnostics, Inc in Q2 2021, selling an estimated $576K.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $735M portfolio in Q2 2021.
  • Spearhead Capital Advisors opened 10 new positions and closed 4 in Q2 2021.
  • Spearhead Capital Advisors's portfolio value rose 8.5% quarter-over-quarter to $735M.

Based on Spearhead Capital Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.